Envoy Medical (COCHW) Return on Equity (2021 - 2026)

Envoy Medical has disclosed Return on Equity across 6 years of filings, most recently posting 0.24% for Q1 2026.

• Return on Equity for Q1 2026 came in at 0.24%, up 23.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.24% (up 23.0% YoY), and the FY2025 annual result was 0.02%, changed 0.0% from the prior year.
• Return on Equity came in at 0.24% for Q1 2026 at Envoy Medical, up from 0.02% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.24% in Q1 2026 to a low of 0.07% in Q4 2023.
• The 5-year median for Return on Equity is 0.01% (2025), against an average of 0.02%.
• Across the five-year window, Return on Equity decreased 6 bps in 2023 and grew 23 bps in 2026, its largest moves.
• Envoy Medical's Return on Equity stood at 0.01% in 2022, then plunged by 1004 bps to 0.07% in 2023, then surged by 115 bps to 0.01% in 2024, then jumped by 124 bps to 0.02% in 2025, then jumped by 907 bps to 0.24% in 2026.
• The last three Return on Equity figures came in at 0.24% (Q1 2026), 0.02% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.